2015
DOI: 10.1186/s12890-015-0044-9
|View full text |Cite
|
Sign up to set email alerts
|

Patients’ perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy

Abstract: BackgroundAlthough asthma morbidity can be prevented through long-term controller medication, most patients with persistent asthma do not take their daily inhaled corticosteroid. The objective of this study was to gather patients’ insights into barriers and facilitators to taking long-term daily inhaled corticosteroids as basis for future knowledge translation interventions.MethodsWe conducted a collective qualitative case study. We interviewed 24 adults, adolescents, or parents of children, with asthma who ha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
51
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(51 citation statements)
references
References 41 publications
0
51
0
Order By: Relevance
“…As described by Pelaez et al [21], patients’ adherence to asthma guideline recommended treatment must be considered on several levels; the patients themselves, the doctor-patient relationship and the health care system. We have previously investigated doctors’ knowledge of the AG [12] and here we focus on the patients’ motivation and wishes in the search for relevant barriers to a more successful AG implementation and therefore to effective evidence based treatment of asthma patients.…”
Section: Discussionmentioning
confidence: 99%
“…As described by Pelaez et al [21], patients’ adherence to asthma guideline recommended treatment must be considered on several levels; the patients themselves, the doctor-patient relationship and the health care system. We have previously investigated doctors’ knowledge of the AG [12] and here we focus on the patients’ motivation and wishes in the search for relevant barriers to a more successful AG implementation and therefore to effective evidence based treatment of asthma patients.…”
Section: Discussionmentioning
confidence: 99%
“…The reasons for non-adherence are varied and are likely to include insufficient inhaler technique, the complexity of the therapeutic regimens (e.g. multiple daily dosing) as well as patient’s beliefs about therapy, such as fear of adverse effects or the perception that medication should be used in response to symptoms more than on a regular basis [10, 13]. In keeping with the latter observation, in our study a high percentage (>40%) of patients discontinued the treatment when they felt better, suggesting a “symptoms, no asthma” belief.…”
Section: Discussionmentioning
confidence: 99%
“…5,6 Inhaled corticosteroids, the mainstay of asthma controller medications and asthma management, decrease asthma symptoms and reduce emergency room visits, hospitalizations, and death, 7 yet less than 50% of older adults with asthma use them as prescribed. 8,9 There are various factors associated with underuse of asthma controller medications ranging from barriers to the specific treatment, including complex and costly regimens, 10 patient/provider-level barriers, such as provider perceptions about the time required to complete patient counseling 11,12 and a poor patient-provider relationship, 13 to patient-level barriers including polypharmacy from a combination of chronic conditions 14 and a lack of motivation to manage chronic illnesses. 13 A growing body of research highlights the impact of 3 additional patient-level factors: (1) limitations in health literacy, defined by the Institute of Medicine as “the degree to which individuals have the capacity to obtain, process and understand basic health information and services needed to make appropriate health decisions,” 15 (2) misconceptions about asthma and the medications used to treat it, 16 and (3) impairments in cognition.…”
mentioning
confidence: 99%